These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19772639)

  • 1. Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records.
    Hivert MF; Grant RW; Shrader P; Meigs JB
    BMC Health Serv Res; 2009 Sep; 9():170. PubMed ID: 19772639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
    Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
    BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
    DeBoer MD; Filipp SL; Gurka MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes.
    Gurka MJ; Guo Y; Filipp SL; DeBoer MD
    Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients.
    Mayer O; Bruthans J; Seidlerová J; Karnosová P; Vaněk J; Hronová M; Gelžinský J; Cvíčela M; Wohlfahrt P; Cífková R; Filipovský J
    Eur J Intern Med; 2018 Jan; 47():55-61. PubMed ID: 28755847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome in patients with first-ever ischemic stroke: prevalence and association with coronary heart disease.
    Liang Y; Yan Z; Hao Y; Wang Q; Zhang Z; She R; Wang P; Du Y; Lau JT; Dekker J; Bai B; Qiu C
    Sci Rep; 2022 Jul; 12(1):13042. PubMed ID: 35906390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease.
    Zhang Y; Hong J; Gu W; Gui M; Chen Y; Zhang Y; Chi Z; Wang W; Li X; Ning G
    Endocrine; 2009 Oct; 36(2):233-8. PubMed ID: 19618299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified metabolic syndrome criteria for identification of patients at risk of developing diabetes and coronary heart diseases: longitudinal assessment via electronic health records.
    Hivert MF; Dusseault-Bélanger F; Cohen A; Courteau J; Vanasse A
    Can J Cardiol; 2012; 28(6):744-9. PubMed ID: 22552176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi-Ethnic Study of Atherosclerosis (MESA): A latent class analysis.
    Riahi SM; Moamer S; Namdari M; Mokhayeri Y; Pourhoseingholi MA; Hashemi-Nazari SS
    Int J Cardiol; 2018 Nov; 271():13-18. PubMed ID: 29885819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and impact of metabolic syndrome in patients with multivessel coronary artery disease and acute coronary syndrome.
    Zhou J; Liu C; Zhou P; Li J; Chen R; Wang Y; Zhao X; Zhao H; Song L; Yan H
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2693-2699. PubMed ID: 34344543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiometabolic responses to cardiac rehabilitation in people with and without diabetes.
    Laddu DR; Ozemek C; Hauer TL; Rouleau CR; Campbell TS; Wilton SB; Aggarwal S; Austford L; Arena R
    Int J Cardiol; 2020 Feb; 301():156-162. PubMed ID: 31806276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?
    Wang JJ; Li HB; Kinnunen L; Hu G; Järvinen TM; Miettinen ME; Yuan S; Tuomilehto J
    Atherosclerosis; 2007 May; 192(1):161-8. PubMed ID: 16720024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
    Wannamethee SG; Shaper AG; Lennon L; Morris RW
    Arch Intern Med; 2005 Dec 12-26; 165(22):2644-50. PubMed ID: 16344423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
    Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS; Lip GY; Beevers DG; Blann AD
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
    Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
    Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
    Sattar N; Gaw A; Scherbakova O; Ford I; O'Reilly DS; Haffner SM; Isles C; Macfarlane PW; Packard CJ; Cobbe SM; Shepherd J
    Circulation; 2003 Jul; 108(4):414-9. PubMed ID: 12860911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
    Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
    Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.